532983 Stock Overview
An integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
RPG Life Sciences Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹2,573.00 |
| 52 Week High | ₹2,976.70 |
| 52 Week Low | ₹1,290.30 |
| Beta | 0.48 |
| 11 Month Change | -1.48% |
| 3 Month Change | 36.48% |
| 1 Year Change | 72.35% |
| 33 Year Change | 270.78% |
| 5 Year Change | 787.09% |
| Change since IPO | 5,767.73% |
Recent News & Updates
Recent updates
Shareholder Returns
| 532983 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 5.2% | 2.0% | 1.8% |
| 1Y | 72.3% | 58.6% | 36.8% |
Return vs Industry: 532983 exceeded the Indian Pharmaceuticals industry which returned 58.6% over the past year.
Return vs Market: 532983 exceeded the Indian Market which returned 36.8% over the past year.
Price Volatility
| 532983 volatility | |
|---|---|
| 532983 Average Weekly Movement | 7.0% |
| Pharmaceuticals Industry Average Movement | 6.3% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in IN Market | 9.4% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 532983 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 532983's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1968 | 1,270 | Yugal Kishor Sikri | www.rpglifesciences.com |
RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmentics, anti-convulsant, and anti-spasmodic, etc. It also provides generics for immunosuppressant therapy; and finished dosage formulations for various therapies, which include nephrology, rheumatology, oncology, gastroenterology, cardiology, orthopedics, nutritional, diabetology, respiratory, neuropsychiatry, urology, vitamins and minerals, gastrointestinal, pain management, anti-diabetic, gynecology, cardiovascular, pediatrics, neurology, anti-dengue, and dermatology, etc. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is headquartered in Mumbai, India.
RPG Life Sciences Limited Fundamentals Summary
| 532983 fundamental statistics | |
|---|---|
| Market cap | ₹42.59b |
| Earnings (TTM) | ₹923.20m |
| Revenue (TTM) | ₹6.00b |
46.1x
P/E Ratio7.1x
P/S RatioIs 532983 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 532983 income statement (TTM) | |
|---|---|
| Revenue | ₹6.00b |
| Cost of Revenue | ₹1.94b |
| Gross Profit | ₹4.06b |
| Other Expenses | ₹3.13b |
| Earnings | ₹923.20m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 07, 2024
| Earnings per share (EPS) | 55.82 |
| Gross Margin | 67.63% |
| Net Profit Margin | 15.39% |
| Debt/Equity Ratio | 0% |
How did 532983 perform over the long term?
See historical performance and comparison